Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,169
Stocks News & Analysis
stocks
ASX energy giant undervalued despite commissioning challenges
stocks
Undervalued ASX share upgrades guidance
stocks
ASX major bank drives strong quarterly profit
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,112.00 | 79.70 | 0.88% |
| CAC 40 | 8,428.07 | 22.01 | 0.26% |
| DAX 40 | 25,338.21 | 22.82 | -0.09% |
| Dow JONES (US) | 52,531.97 | 321.89 | 0.62% |
| FTSE 100 | 10,850.19 | 68.44 | 0.63% |
| HKSE | 25,310.85 | 103.67 | 0.41% |
| NASDAQ | 24,602.99 | 329.09 | -1.32% |
| Nikkei 225 | 62,364.92 | 2,566.27 | -3.95% |
| NZX 50 Index | 13,861.93 | 11.24 | 0.08% |
| S&P 500 | 7,386.49 | 26.69 | -0.36% |
| S&P/ASX 200 | 8,947.80 | 85.60 | 0.97% |
| SSE Composite Index | 3,813.31 | 44.93 | -1.16% |